Evaluation of Serum Concentration of the Myokine Irisin (FNDC5) in Patients with Age-Related

Overview

Journal Beyoglu Eye J

Publisher Kare Publishing

Specialty Ophthalmology

Date 2022 Jan 10

PMID 35005513

Authors

Burak Turgut

Kadir Mercan

Nevin Ilhan

Selahattin Semih Aydogan

Affiliations

Soon will be listed here.

Abstract

Objectives: This study evaluated the serum irisin level of patients with age-related macular degeneration (ARMD) and compared it with that of healthy individuals.

Methods: The serum irisin level of 15 healthy controls (Group 1) and 15 dry ARMD patients (Group 2) and 15 wet ARMD patients (Group 3) were measured using the enzyme-linked immunosorbent assay (ELISA) method and compared.

Results: There was no statistically significant difference between the groups in terms of age or gender (p>0.05). The mean serum irisin levels of Group 1, Group 2, and Group 3 were 25.81±24.04 ng/mL, 22.93±19.05 ng/mL, and 12.38±8.16 ng/mL, respectively. Although the mean irisin level in the wet ARMD patients was lower than that of the control and dry ARMD groups, there was no statistically significant difference between the groups (p>0.05).

Conclusion: The results suggest that the serum irisin level in ARMD patients is not different from that of healthy individuals. Studies of larger groups that examine the irisin level in the vitreous and neovascular membranes will further elucidate any role in the pathogenesis of ARMD.

References

Grygiel-Gorniak B, Puszczewicz M . A review on irisin, a new protagonist that mediates muscle-adipose-bone-neuron connectivity. Eur Rev Med Pharmacol Sci. 2017; 21(20):4687-4693. View

Patel M, Chan C . Immunopathological aspects of age-related macular degeneration. Semin Immunopathol. 2008; 30(2):97-110. PMC: 2441602. DOI: 10.1007/s00281-008-0112-9. View

Penn J, Madan A, Caldwell R, Bartoli M, Caldwell R, Hartnett M . Vascular endothelial growth factor in eye disease. Prog Retin Eye Res. 2008; 27(4):331-71. PMC: 3682685. DOI: 10.1016/j.preteyeres.2008.05.001. View

Knickelbein J, Chan C, Sen H, Ferris F, Nussenblatt R . Inflammatory Mechanisms of Age-related Macular Degeneration. Int Ophthalmol Clin. 2015; 55(3):63-78. PMC: 4472429. DOI: 10.1097/IIO.0000000000000073. View

Albayrak S, Atci I, Kalayci M, Yilmaz M, Kuloglu T, Aydin S . Effect of carnosine, methylprednisolone and their combined application on irisin levels in the plasma and brain of rats with acute spinal cord injury. Neuropeptides. 2015; 52:47-54. DOI: 10.1016/j.npep.2015.06.004. View

Okonkwo O, Schultz S, Oh J, Larson J, Edwards D, Cook D . Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology. 2014; 83(19):1753-60. PMC: 4239838. DOI: 10.1212/WNL.0000000000000964. View

Wu J, Sun X . Complement system and age-related macular degeneration: drugs and challenges. Drug Des Devel Ther. 2019; 13:2413-2425. PMC: 6650090. DOI: 10.2147/DDDT.S206355. View

Huh J, Panagiotou G, Mougios V, Brinkoetter M, Vamvini M, Schneider B . FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012; 61(12):1725-38. PMC: 3614417. DOI: 10.1016/j.metabol.2012.09.002. View

Ambati J, Atkinson J, Gelfand B . Immunology of age-related macular degeneration. Nat Rev Immunol. 2013; 13(6):438-51. PMC: 3941009. DOI: 10.1038/nri3459. View

10.

Wrann C, White J, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D . Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5):649-59. PMC: 3980968. DOI: 10.1016/j.cmet.2013.09.008. View

11.

Li D, Li Y, Yuan H, Qu L, Wang P . The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia. Metabolism. 2017; 68:31-42. DOI: 10.1016/j.metabol.2016.12.003. View

12.

Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L . Irisin - a myth rather than an exercise-inducible myokine. Sci Rep. 2015; 5:8889. PMC: 4352853. DOI: 10.1038/srep08889. View

13.

Diniz B, Teixeira A . Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. Neuromolecular Med. 2011; 13(4):217-22. DOI: 10.1007/s12017-011-8154-x. View

14.

Gur F, Timurkaan S, Gencer Tarakci B, Yalcin M, Ozkan Z, Baygeldi S . Identification of immunohistochemical localization of irisin in the dwarf hamster (Phodopus roborovskii) tissues. Anat Histol Embryol. 2018; 47(2):174-179. DOI: 10.1111/ahe.12345. View

15.

Bostrom P, Wu J, Jedrychowski M, Korde A, Ye L, Lo J . A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-8. PMC: 3522098. DOI: 10.1038/nature10777. View

16.

Quinn L, Anderson B, Conner J, Wolden-Hanson T . Circulating irisin levels and muscle FNDC5 mRNA expression are independent of IL-15 levels in mice. Endocrine. 2015; 50(2):368-77. DOI: 10.1007/s12020-015-0607-9. View

17.

Tarboush N, Abu-Yaghi N, Al Ejeilat L, Wahed R, Jeris I . Association of Irisin Circulating Level with Diabetic Retinopathy: A Case-Control Study. Exp Clin Endocrinol Diabetes. 2018; 129(1):36-42. DOI: 10.1055/a-0723-3749. View

18.

Panati K, Suneetha Y, Narala V . Irisin/FNDC5--An updated review. Eur Rev Med Pharmacol Sci. 2016; 20(4):689-97. View

19.

Dun S, Lyu R, Chen Y, Chang J, Luo J, Dun N . Irisin-immunoreactivity in neural and non-neural cells of the rodent. Neuroscience. 2013; 240:155-62. PMC: 3637839. DOI: 10.1016/j.neuroscience.2013.02.050. View

20.

Gouveia M, Vella J, Cafeo F, Affonso Fonseca F, Bacci M . Association between irisin and major chronic diseases: a review. Eur Rev Med Pharmacol Sci. 2016; 20(19):4072-4077. View